Pilulka Lékárny a.s. has completed an IPO on the START Market of the Prague Stock Exchange
Pilulka Lékárny a.s. has completed an IPO on the START Market of the Prague Stock Exchange consisting of a capital increase and the disposal of secondary shares.
Founded in 2013, Pilulka is one of the most significant players consolidating the online and offline pharmacy markets in Central Europe. Pilulka is the number one pharmacy e-shop in the home delivery segment in the Czech Republic and Slovakia, and among the top three retail pharmacy chains in the Czech Republic, with 152 branded pharmacies. The company entered the Romanian online pharmacy market in 2018 and plans to expand into Hungary in 2021. Pilulka is a data-driven market disruptor leveraging its tailor-made and easily scalable IT solutions. Furthermore, the company is backed by a strong management team led by Czech e-commerce tycoons Petr and Martin Kasa, who founded the company.
Oaklins’ team in the Czech Republic acted as the IPO manager in this transaction. The team succeeded in attracting orders from high-net-worth individuals and experienced investors, and also from a broad range of retail and institutional investors.
Talk to the deal team
Related deals
Winking Studios Limited completes a secondary fundraising of US$20 million
Winking Studios has successfully raised US$20 million to fund its business strategy and future plans, such as strategic acquisitions, alliances and joint ventures as well as secondary or dual listings, to grow the group’s market share and broaden its customer base globally.
Learn moreUniKidz has partnered with Karmijn Kapitaal
Karmijn Kapitaal has acquired a majority stake in UniKidz, a talent development organization that provides a scientifically-based developmental approach through high-quality childcare. Through the partnership with Karmijn Kapitaal, UniKidz can take the next step in bringing their unique concept to even more children.
Learn moreProvital GmbH has been acquired by EMERAM Capital Partners
Dr. Thomas Brandner has sold a majority stake in Provital GmbH to private equity firm EMERAM Capital Partners. The transaction secures the future development and growth opportunities of the pet food company as EMERAM Capital Partners takes on ownership and acts as its strategic partner.
Learn more